Richi, Patricia http://orcid.org/0000-0003-2277-6814
Alonso, Oriol
Martín, María Dolores
González-Hombrado, Laura
Navío, Teresa
Salido, Marina
Llorente, Jesús
Andreu-Vázquez, Cristina
García-Fernández, Cristina
Jiménez-Diaz, Ana
Lojo, Leticia
Cebrián, Laura
Thuissard-Vasallo, Israel
Martínez de Aramayona, María José
Cobo, Tatiana
García-Castro, Marta
Castro, Patricia
Fernández-Castro, Mónica
Illera, Óscar
Steiner, Martina
Muñoz-Fernández, Santiago
Funding for this research was provided by:
Sociedad de Reumatología Comunidad de Madrid (SORCOM)/MSD (20141)
Sociedad de Reumatología Comunidad de Madrid (SORCOM)/MSD (20141)
Pfizer (NA, NA)
Article History
Received: 5 November 2019
Revised: 12 February 2020
Accepted: 10 March 2020
First Online: 4 April 2020
Compliance with ethical standards
:
: Patricia Richi declares she has received research grants from Sociedad de Reumatología Comunidad de Madrid (SORCOM)/MSD and Pfizer. Santiago Muñoz-Fernández declares he has received research grants from Sociedad de Reumatología Comunidad de Madrid (SORCOM)/MSD and Pfizer. The rest of authors declare that they have no conflict of interest.The funding sources had no role in the study design, collection, analysis or interpretation of the data, writing of the manuscript, or in the decision to submit the manuscript for publication.